Optimization of immune checkpoint inhibitor treatment planning for relapsed or refractory extranodal NK/T cell lymphoma
Annals of Hematology · 2024
DOI: 10.1007/s00277-024-05739-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Sang Eun Yoon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Lymphoma, Extranodal NK-T-Cell, Immune Checkpoint Inhibitors, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
- Department of Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
- Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. wskimsmc@skku.edu.
Zitieren
APA
Yoon, S. E., Cho, H., Berning, P., Cho, J., Kim, H. Y., Yoon, D. H., Schmit, N., Kim, S. J., & Kim, W. S. (2024). Optimization of immune checkpoint inhibitor treatment planning for relapsed or refractory extranodal NK/T cell lymphoma. Annals of Hematology. https://doi.org/10.1007/s00277-024-05739-3
Vancouver
Yoon SE, Cho H, Berning P, Cho J, Kim HY, Yoon DH, et al. Optimization of immune checkpoint inhibitor treatment planning for relapsed or refractory extranodal NK/T cell lymphoma. Annals of Hematology. 2024. doi:10.1007/s00277-024-05739-3
BibTeX
@article{Yoon2024,
author = {Yoon, Sang Eun and Cho, Hyungwoo and Berning, Philipp and Cho, Junhun and Kim, Hyun-Young and Yoon, Dok Hyun and Schmit, Norbert and Kim, Seok Jin and Kim, Won Seog},
title = {Optimization of immune checkpoint inhibitor treatment planning for relapsed or refractory extranodal NK/T cell lymphoma},
journal = {Annals of Hematology},
year = {2024},
doi = {10.1007/s00277-024-05739-3}
}
EUVIMED